当前位置:首页 > 关于我们 > 合作伙伴 > 杭州泰格医药科技股份有限公司

杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co.



杭州泰格医药科技股份有限公司(股票代码:300347),是一家专注于为医药产品研发提供临床试验全过程专业服务的合同研究组织(CRO)。致力为客户降低研发风险、节约研发经费,推进产品市场化进程。 

       公司总部位于杭州,下设30子公司,在中国大陆50个主要城市和香港、台湾、加拿大、美国、韩国、日本、澳大利亚、马来西亚、新加坡等地设有服务网点,拥有1800多人的国际化专业团队,为全球300多家客户成功提供了400余项临床试验服务。泰格医药更因参与50余种国内创新药临床试验,而被誉为 “创新型CRO”。


更多信息可浏览公司网站  www.tigermed.net.


Hangzhou Tigermed Consulting Co., Ltd.(Stock symbol:300347) is a leading Contract Research Organization (CRO) in China dedicated to provide professional full clinical trial services. Since inception in 2004, Tigermed has been committed to accelerating medical product development with costs efficiency and quality.


Headquartered in Hangzhou, Tigermed operates 25 subsidiaries, over 48 offices across China and 9 overseas offices in Hong Kong, Taiwan, USA, Canada, Korea, Australia, Japan, Malaysia and Singapore with over 1500 full-time staffs. Tigermed has serviced more than 300 local and global clients in the conduct of over 400 clinical trials. Tigermed is recognized as “ The Innovative CRO” in China, owning to our involvement of over 50 innovative drugs.


For more information about Tigermed, please visit www.tigermed.net.




0.186527s